Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedSep 25, 2025
DataAggregated Company Financials
Companies9
  • 7D0.1%
  • 3M2.1%
  • 1Y1.5%
  • YTD7.8%

The Pharma industry has stayed flat over the last week. Furthermore, the industry has been flat for the past year as well. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Sep 2025CHF 471.5bCHF 120.1bCHF 20.9b31.4x22.6x3.9x
Sun, 24 Aug 2025CHF 480.6bCHF 120.5bCHF 21.0b31.1x22.9x4x
Tue, 22 Jul 2025CHF 441.5bCHF 118.9bCHF 19.6b24.6x22.6x3.7x
Thu, 19 Jun 2025CHF 444.0bCHF 118.8bCHF 19.2b24.9x23.1x3.7x
Sat, 17 May 2025CHF 432.1bCHF 120.1bCHF 19.5b25x22.2x3.6x
Mon, 14 Apr 2025CHF 393.9bCHF 117.3bCHF 18.4b23.4x21.4x3.4x
Wed, 12 Mar 2025CHF 467.3bCHF 121.6bCHF 19.1b28.5x24.4x3.8x
Fri, 07 Feb 2025CHF 475.3bCHF 122.8bCHF 19.2b22.7x24.8x3.9x
Sun, 05 Jan 2025CHF 429.0bCHF 119.6bCHF 21.4b18x20x3.6x
Tue, 03 Dec 2024CHF 434.6bCHF 118.2bCHF 21.2b18.5x20.5x3.7x
Thu, 31 Oct 2024CHF 452.3bCHF 116.8bCHF 20.9b19.6x21.6x3.9x
Sat, 28 Sep 2024CHF 457.4bCHF 114.3bCHF 19.2b21.9x23.8x4x
Mon, 26 Aug 2024CHF 472.1bCHF 114.7bCHF 19.3b22.5x24.5x4.1x
Wed, 24 Jul 2024CHF 451.4bCHF 117.0bCHF 20.6b32.6x21.9x3.9x
Fri, 21 Jun 2024CHF 431.4bCHF 116.0bCHF 19.7b33.4x21.9x3.7x
Sun, 19 May 2024CHF 417.8bCHF 113.3bCHF 19.9b40.3x21x3.7x
Tue, 16 Apr 2024CHF 402.3bCHF 112.5bCHF 19.5b37.3x20.7x3.6x
Thu, 14 Mar 2024CHF 388.3bCHF 110.3bCHF 19.7b23.7x19.7x3.5x
Sat, 10 Feb 2024CHF 377.4bCHF 110.0bCHF 19.6b24.1x19.2x3.4x
Mon, 08 Jan 2024CHF 412.8bCHF 119.3bCHF 18.6b26.8x22.2x3.5x
Wed, 06 Dec 2023CHF 399.9bCHF 120.9bCHF 18.9b24.5x21.2x3.3x
Fri, 03 Nov 2023CHF 388.0bCHF 122.8bCHF 19.1b23.6x20.3x3.2x
Sun, 01 Oct 2023CHF 407.6bCHF 113.6bCHF 18.2b44.4x22.4x3.6x
Tue, 29 Aug 2023CHF 407.1bCHF 111.9bCHF 17.9b47.6x22.7x3.6x
Thu, 27 Jul 2023CHF 415.8bCHF 114.1bCHF 19.2b36.8x21.7x3.6x
Sat, 24 Jun 2023CHF 425.0bCHF 115.2bCHF 18.9b37.2x22.5x3.7x
Mon, 22 May 2023CHF 434.9bCHF 115.3bCHF 18.9b39.9x23x3.8x
Wed, 19 Apr 2023CHF 434.1bCHF 114.9bCHF 18.8b42.1x23.1x3.8x
Fri, 17 Mar 2023CHF 385.8bCHF 116.5bCHF 19.1b25.8x20.2x3.3x
Sun, 12 Feb 2023CHF 407.7bCHF 116.2bCHF 19.0b29.1x21.4x3.5x
Tue, 10 Jan 2023CHF 435.4bCHF 116.8bCHF 34.5b22.4x12.6x3.7x
Thu, 08 Dec 2022CHF 444.5bCHF 117.9bCHF 35.0b22.9x12.7x3.8x
Sat, 05 Nov 2022CHF 456.4bCHF 120.9bCHF 36.2b22.8x12.6x3.8x
Mon, 03 Oct 2022CHF 443.3bCHF 120.6bCHF 37.0b20.2x12x3.7x
Price to Earnings Ratio

12x


Total Market Cap: CHF 443.3bTotal Earnings: CHF 37.0bTotal Revenue: CHF 120.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 20.9x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swiss Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 20.9x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-0.40%
Healthcare-0.62%
Pharma0.10%
Pharma0.10%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVN NovartisCHF 98.001.3%
+CHF 2.5b		0.1%PE17.5x
DESN Dottikon ES HoldingCHF 303.002.5%
+CHF 103.6m		19.5%PE39.7x
NWRN Newron PharmaceuticalsCHF 10.501.0%
+CHF 2.0m		39.6%PE8.9x

Latest News

SDZ
CHF 46.35
Sandoz Group
7D
-2.1%
1Y
30.2%
ROG
CHF 255.00
Roche Holding
7D
-2.5%
1Y
-5.8%
NOVN
CHF 98.00
Novartis
7D
1.3%
1Y
0.1%
GALD
CHF 135.30
Galderma Group
7D
-5.9%
1Y
71.3%
NWRN
CHF 10.50
Newron Pharmaceuticals
7D
1.0%
1Y
39.6%
DESN
CHF 303.00
Dottikon ES Holding
7D
2.5%
1Y
19.5%

Dottikon ES Holding AG's (VTX:DESN) Business Is Trailing The Market But Its Shares Aren't

Sep 19
Dottikon ES Holding AG's (VTX:DESN) Business Is Trailing The Market But Its Shares Aren't
CURN
CHF 14.40
Curatis Holding
7D
-1.4%
1Y
91.5%
BIOV
CHF 28.90
BioVersys
7D
-7.7%
1Y
n/a
COPN
CHF 63.50
Cosmo Pharmaceuticals
7D
-5.6%
1Y
-17.3%

Expanding AI Diagnostics And Drug Platforms Will Navigate Regulatory Challenges

Cosmo Pharmaceuticals’ consensus revenue growth forecasts have strengthened and its future P/E valuation has decreased, but despite these more favourable fundamentals, the consensus analyst price target was only marginally reduced from CHF88.37 to CHF87.81. What's in the News Issued FY2025 guidance: total revenues expected between EUR 102 million and EUR 107 million, with recurring revenues of EUR 85 million to EUR 90 million and project-based revenues of EUR 17 million.
ADXN
CHF 0.066
Addex Therapeutics
7D
-2.1%
1Y
-8.5%